The Fenton Activity of Iron(III) in the Presence of Deferiprone
- 1 April 2008
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 97 (4), 1454-1467
- https://doi.org/10.1002/jps.21039
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Redox Properties of the Iron Complexes of Orally Active Iron Chelators CP20, CP502, CP509, and ICL670Helvetica Chimica Acta, 2004
- Design of iron chelators with therapeutic applicationCoordination Chemistry Reviews, 2002
- Speciation of Fe(III)–chelate complexes by electrospray ionization ion trap and laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometryRapid Communications in Mass Spectrometry, 2002
- Design of clinically useful iron(III)‐selective chelatorsMedicinal Research Reviews, 2001
- DeferiproneDrugs, 1999
- Iron Chelators for ThalassaemiaBritish Journal of Haematology, 1998
- Iron chelation therapyJournal of Internal Medicine, 1997
- Long‐term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trialBritish Journal of Haematology, 1992
- Development of iron-chelating agents for clinical use [editorial; comment]Blood, 1992
- Crystal structure of the tris 1,2-dimethyl-3-hydroxy-4-pyridinone (DMHP) complex with the Fe(III) ionInorganica Chimica Acta, 1992